Open access
Sep 2026
FXYD5 promotes the growth of glioblastoma by targeting the PI3K/AKT/ACSL4 signaling axis
Findings revealed that FXYD5 promotes GBM progression via the PI3K/AKT/ACSL4 signaling axis and represents a potential therapeutic target for GBM.
Bang-Rong Wang, Yong Qin, Hang Cheng et al.
· Oncology Report · 0 citations